Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Mar'17
Net Sales
187.10
237.29
861.47
1,058.80
1,315.17
1,185.66
1,461.91
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
187.10
237.29
861.47
1,058.80
1,315.17
1,185.66
1,461.91
Raw Material Cost
109.95
153.00
356.56
483.24
561.91
489.80
565.83
Purchase of Finished goods
0.80
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
160.76
0.48
-2.04
-20.69
-43.51
-10.13
-29.55
Employee Cost
32.67
36.22
195.66
233.36
241.76
197.78
189.98
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.01
0.00
0.00
296.21
333.11
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
70.22
55.65
287.50
354.78
377.87
-0.00
-0.00
Total Expenditure (Excl Depreciation)
374.40
245.35
837.69
1,050.69
1,138.03
973.66
1,059.37
Operating Profit (PBDIT) excl Other Income
-187.30
-8.06
23.78
8.11
177.14
212.00
402.54
Other Income
0.97
1.27
9.82
8.26
22.96
9.61
8.09
Operating Profit (PBDIT)
-186.33
-6.79
33.60
16.37
200.10
221.61
410.63
Interest
35.90
39.76
53.88
58.89
67.26
79.48
65.87
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
-222.23
-46.55
-20.28
-42.52
132.84
142.13
344.76
Depreciation
108.41
18.28
55.49
66.95
66.79
56.42
58.28
Profit Before Tax
-330.65
-64.83
-75.77
-109.47
66.05
85.71
286.48
Tax
-2.12
2.82
2.03
-0.36
8.68
9.62
72.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-328.53
-67.65
-77.80
-109.12
57.37
76.09
213.98
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-328.53
-67.65
-77.80
-109.12
57.37
76.09
213.98
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
1.85
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-328.53
-67.65
-77.80
-109.12
57.37
77.94
213.98
Equity Capital
16.58
16.58
16.58
16.58
16.50
16.51
16.20
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
22.84
347.70
414.99
492.79
0.00
884.67
718.01
Earnings per share (EPS)
-39.63
-8.16
-9.38
-13.16
6.95
9.44
26.41
Diluted Earnings per share
-38.46
-7.92
-9.11
-12.77
6.67
9.21
25.62
Operating Profit Margin (Excl OI)
-100.11%
-3.4%
2.76%
0.77%
13.47%
17.88%
27.54%
Gross Profit Margin
-118.78%
-19.62%
-2.35%
-4.02%
10.1%
11.99%
23.58%
PAT Margin
-175.59%
-28.51%
-9.03%
-10.31%
4.36%
6.42%
14.64%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2023 is -21.15% vs -72.46% in Mar 2022
Consolidate Net Profit
YoY Growth in year ended Mar 2023 is -385.63% vs 13.05% in Mar 2022
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2023 is -2,223.82% vs -133.89% in Mar 2022
Interest
YoY Growth in year ended Mar 2023 is -9.71% vs -26.21% in Mar 2022
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2023 has fallen from Mar 2022
Compare Annual Results Of Vivimed Labs. With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
187.10
32,643.90
-32,456.80
-99.43%
Other Operating Income
0.00
0.00
0.00
Total Operating income
187.10
32,643.90
-32,456.80
-99.43%
Raw Material Cost
109.95
5,683.50
-5,573.55
-98.07%
Purchase of Finished goods
0.80
4,841.10
-4,840.30
-99.98%
(Increase) / Decrease In Stocks
160.76
-544.70
705.46
129.51%
Employee Cost
32.67
5,580.00
-5,547.33
-99.41%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
70.22
8,536.90
-8,466.68
-99.18%
Total Expenditure (Excl Depreciation)
374.40
24,096.80
-23,722.40
-98.45%
Operating Profit (PBDIT) excl Other Income
-187.30
8,547.10
-8,734.40
-102.19%
Other Income
0.97
1,097.30
-1,096.33
-99.91%
Operating Profit (PBDIT)
-186.33
9,644.40
-9,830.73
-101.93%
Interest
35.90
282.90
-247.00
-87.31%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
-222.23
9,361.50
-9,583.73
-102.37%
Depreciation
108.41
1,703.70
-1,595.29
-93.64%
Profit Before Tax
-330.65
7,657.80
-7,988.45
-104.32%
Tax
-2.12
1,954.30
-1,956.42
-100.11%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-328.53
5,703.50
-6,032.03
-105.76%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-328.53
5,703.50
-6,032.03
-105.76%
Share in Profit of Associates
0.00
21.70
-21.70
-100.00%
Minority Interest
0.00
-70.10
70.10
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-328.53
5,655.10
-5,983.63
-105.81%
Equity Capital
16.58
83.40
-66.82
-80.12%
Face Value
2.00
1.00
0.00
Reserves
22.84
33,466.20
-33,443.36
-99.93%
Earnings per share (EPS)
-39.63
67.81
-107.44
-158.44%
Diluted Earnings per share
-38.46
67.79
-106.25
-156.73%
Operating Profit Margin (Excl OI)
-100.11%
26.26%
0.00
-126.37%
Gross Profit Margin
-118.78%
28.76%
0.00
-147.54%
PAT Margin
-175.59%
17.59%
0.00
-193.18%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 187.10 Cr
in Mar 2023Figures in Cr
YoY Growth in year ended Mar 2023 is -21.15% vs -72.46% in Mar 2022
Annual - Consolidate Net Profit
Consolidate Net Profit -328.53 Cr
in Mar 2023Figures in Cr
YoY Growth in year ended Mar 2023 is -385.63% vs 13.05% in Mar 2022
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -187.30 Cr
in Mar 2023Figures in Cr
YoY Growth in year ended Mar 2023 is -2,223.82% vs -133.89% in Mar 2022
Annual - Interest
Interest 35.90 Cr
in Mar 2023Figures in Cr
YoY Growth in year ended Mar 2023 is -9.71% vs -26.21% in Mar 2022
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -100.11%
in Mar 2023Figures in %
YoY Growth in year ended Mar 2023 has fallen from Mar 2022






